FDA Clearance Tracker · K191194
CLARUS
Last checked: Nov 20, 2026Latest source record: Jun 25, 2019 (this decision)Source: openFDAMethods & limitations
Decided
Jun 25, 2019
Substantially Equivalent
Time to decision
53 days
Received May 3, 2019. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Class II
The decision
- FDA number
- K191194
- Device name
- CLARUS
- Applicant
- Carl Zeiss Meditec, Inc.
- Applicant location
- Dublin, CA
- Received
- May 3, 2019
- Decided
- Jun 25, 2019
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Device type
- Camera, Ophthalmic, Slit-Scanning (QER)
- Device class
- Class II
- Regulation
- 21 CFR 886.1120
- Specialty
- Ophthalmology
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code QER. The earliest in FDA's data is K181444, decided Jan 10, 2019.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K191194
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Carl Zeiss Meditec, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- CLARUS (700)510(k)
K243878 · Decided Apr 17, 2025 · 120 days after receipt
Device type: Camera, Ophthalmic, Slit-Scanning (QER) · Ophthalmology
- MEL90PMA supplement
P060004-S006 · Decided Dec 4, 2024 · 471 days after receipt · Panel Track
Device type: Excimer laser system (LZS) · Ophthalmology
K233933 · Decided May 17, 2024 · 155 days after receipt
Device type: Tomography, Optical Coherence (OBO) · Ophthalmology
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.